- Home
- PLX vs ADUR Comparison
PLX vs ADUR Comparison
Compare PLX & ADUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- ADUR
- Stock Information
- Founded
- PLX 1993
- ADUR 2011
- Country
- PLX Israel
- ADUR Canada
- Employees
- PLX N/A
- ADUR N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- ADUR
- Sector
- PLX Health Care
- ADUR
- Exchange
- PLX Nasdaq
- ADUR NYSE
- Market Cap
- PLX 132.5M
- ADUR 154.9M
- IPO Year
- PLX 1998
- ADUR N/A
- Fundamental
- Price
- PLX $1.76
- ADUR $5.51
- Analyst Decision
- PLX
- ADUR
- Analyst Count
- PLX 0
- ADUR 0
- Target Price
- PLX N/A
- ADUR N/A
- AVG Volume (30 Days)
- PLX 382.4K
- ADUR 66.1K
- Earning Date
- PLX 11-14-2024
- ADUR 01-01-0001
- Dividend Yield
- PLX N/A
- ADUR N/A
- EPS Growth
- PLX N/A
- ADUR N/A
- EPS
- PLX N/A
- ADUR N/A
- Revenue
- PLX $45,667,000.00
- ADUR $247,485.00
- Revenue This Year
- PLX N/A
- ADUR N/A
- Revenue Next Year
- PLX $88.94
- ADUR N/A
- P/E Ratio
- PLX N/A
- ADUR N/A
- Revenue Growth
- PLX N/A
- ADUR 98.59
- 52 Week Low
- PLX $0.82
- ADUR $1.34
- 52 Week High
- PLX $1.90
- ADUR $7.00
- Technical
- Relative Strength Index (RSI)
- PLX 62.98
- ADUR N/A
- Support Level
- PLX $1.60
- ADUR N/A
- Resistance Level
- PLX $1.83
- ADUR N/A
- Average True Range (ATR)
- PLX 0.08
- ADUR 0.00
- MACD
- PLX -0.02
- ADUR 0.00
- Stochastic Oscillator
- PLX 71.15
- ADUR 0.00
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About ADUR ADURO CLEAN TECHNOLOGIES INC
Aduro Clean Technologies Inc is a developer of patented water-based technologies to chemically recycle plastics and transform heavy crude and renewable oils into feedstocks and higher-value fuels. The company's technology activates unique properties of water in a chemistry platform that operates at relatively low temperatures and costs.